Atlas Trials

A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease

Clinical trial NCT00838396 · COMPLETED

Trial details

NCT number
NCT00838396
Sponsor
Indivior Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GERD
Start date
2005-10-01
Primary completion
2006-08-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.